The potential of melanoma antigen expression in cancer therapy

被引:41
作者
Gillespie, AM [1 ]
Coleman, RE [1 ]
机构
[1] Weston Pk Hosp, Yorkshire Canc Res Dept Clin ONcol, Sheffield S10 2SJ, S Yorkshire, England
关键词
tumour-associated antigen; MAGE; cancer immunotherapy;
D O I
10.1053/ctrv.1999.0126
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A potential new therapy for cancer is active specific immunotherapy with melanoma antigen (MAGE) gene products. The MAGE gene family comprizes a series of 12 closely related genes, some of which have been shown to be expressed in a variety of tumours of different histological origin. Peptides encoded by the MAGE genes are targets for specific immunotherapy as they are presented in association with human leucocyte antigen class I molecules and are recognised by cytotoxic T lymphocytes. This article reviews the discovery, development, role and therapeutic potential of MAGE tumour-associated antigens. Knowledge in this field of study is in its early stages. Future advances can be anticipated in term of defining therapeutic relevance, antigen detection and discovery of related genes.
引用
收藏
页码:219 / 227
页数:9
相关论文
共 88 条
[1]   THE TUMOR PROTEIN MAGE-1 IS LOCATED IN THE CYTOSOL OF HUMAN-MELANOMA CELLS [J].
AMARCOSTESEC, A ;
GODELAINE, D ;
STOCKERT, E ;
VANDERBRUGGEN, P ;
BEAUFAY, H ;
CHEN, YT .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 204 (02) :710-715
[2]   A MEMBER OF THE MELANOMA ANTIGEN-ENCODING GENE (MAGE) FAMILY IS EXPRESSED IN HUMAN SKIN DURING WOUND-HEALING [J].
BECKER, JC ;
GILLITZER, R ;
BROCKER, EB .
INTERNATIONAL JOURNAL OF CANCER, 1994, 58 (03) :346-348
[3]   BAGE - A NEW GENE ENCODING AN ANTIGEN RECOGNIZED ON HUMAN MELANOMAS BY CYTOLYTIC T-LYMPHOCYTES [J].
BOEL, P ;
WILDMANN, C ;
SENSI, ML ;
BRASSEUR, R ;
RENAULD, JC ;
COULIE, P ;
BOON, T ;
VANDERBRUGGEN, P .
IMMUNITY, 1995, 2 (02) :167-175
[4]  
BOON T, 1993, SCI AM, V268, P82
[5]   EXPRESSION OF MAGE GENES IN PRIMARY AND METASTATIC CUTANEOUS MELANOMA [J].
BRASSEUR, F ;
RIMOLDI, D ;
LIENARD, D ;
LETHE, B ;
CARREL, S ;
ARIENTI, F ;
SUTER, L ;
VANWIJCK, R ;
BOURLOND, A ;
HUMBLET, Y ;
VACCA, A ;
CONESE, M ;
LAHAYE, T ;
DEGIOVANNI, G ;
DERAEMAECKER, R ;
BEAUDUIN, M ;
SASTRE, X ;
SALAMON, E ;
DRENO, B ;
JAGER, E ;
KNUTH, A ;
CHEVREAU, C ;
SUCIU, S ;
LACHAPELLE, JM ;
POUILLART, P ;
PARMIANI, G ;
LEJEUNE, F ;
CEROTTINI, JC ;
BOON, T ;
MARCHAND, M .
INTERNATIONAL JOURNAL OF CANCER, 1995, 63 (03) :375-380
[6]  
Carrel S, 1996, INT J CANCER, V67, P417, DOI 10.1002/(SICI)1097-0215(19960729)67:3<417::AID-IJC17>3.0.CO
[7]  
2-4
[8]   IDENTIFICATION OF POTENTIAL CTL EPITOPES OF TUMOR-ASSOCIATED ANTIGEN MAGE-1 FOR 5 COMMON HLA-A ALLELES [J].
CELIS, E ;
FIKES, J ;
WENTWORTH, P ;
SIDNEY, J ;
SOUTHWOOD, S ;
MAEWAL, A ;
DELGUERCIO, MF ;
SETTE, A ;
LIVINGSTON, B .
MOLECULAR IMMUNOLOGY, 1994, 31 (18) :1423-1430
[9]   INDUCTION OF ANTITUMOR CYTOTOXIC T-LYMPHOCYTES IN NORMAL HUMANS USING PRIMARY CULTURES AND SYNTHETIC PEPTIDE EPITOPES [J].
CELIS, E ;
TSAI, V ;
CRIMI, C ;
DEMARS, R ;
WENTWORTH, PA ;
CHESNUT, RW ;
GREY, HM ;
SETTE, A ;
SERRA, HM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) :2105-2109
[10]   Expression of MAGE genes in ocular melanoma during progression from primary to metastatic disease [J].
Chen, PW ;
Murray, TG ;
Uno, T ;
Salgaller, ML ;
Reddy, R ;
Ksander, BR .
CLINICAL & EXPERIMENTAL METASTASIS, 1997, 15 (05) :509-518